Avacta Group plc
Avacta Group plc is a clinical stage biopharmaceutical company focused on drug delivery methods to improve the effectiveness of cancer therapeutics. The company has a research and development facility and a team of scientists and management located in London and the US.
- Affimer drug conjugates
- Rapid diagnostic test kits
- pre|CISION peptide drug conjugates
Locations
Competitors
Creasallis is a biopharmaceutical company focused on innovative antibody therapeutics solutions, particularly in the field of cancer treatment.
Sutura Therapeutics is a biopharmaceutical company dedicated to advancing the field of biomolecular medicine through its peptide-based drug conjugate platform.
Iksuda Therapeutics is dedicated to creating class-leading antibody-drug conjugates (ADCs) with enhanced tumour specificity for hard-to-treat cancers.
Company Details
Avacta Group plc is operated by Avacta Group Plc and is a Active company incorporated on 29 April 2003 with the registered office located in London, Greater London. Avacta Group Plc was registered 22 years ago.
Status
Active
Size
Medium
Directors
7
Age
22 years old
Employees
151
Turnover
Unreported
Total Assets
£48.27M
Cash in Bank
£12.87M
Total Liabilities
-£38.99M